Combined inhibition of Aurora-A and ATR kinase results in regression of MYCN-amplified neuroblastoma. (2021)

First Author: Roeschert I
Attributed to:  Institute of Cancer Research Confidence in Concept (ICR CiC) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s43018-020-00171-8

PubMed Identifier: 33768209

Publication URI: http://europepmc.org/abstract/MED/33768209

Type: Journal Article/Review

Volume: 2

Parent Publication: Nature cancer

Issue: 3

ISSN: 2662-1347